Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Prospective Random Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer

NCT04138992 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT04138992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04138992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Prospective Random Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer
Lead sponsor
Air Force Military Medical University, China
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 1, 2020
Completion date
May 31, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disease free survival